According to the most recent financial data from September 2026, the EPS for the trailing twelve months is $12.29. CME Group's EPS for 2025 amounted to $11.18, marking an increase from $9.69 in 2024. During the quarterly period ending on Sep 30, 2026, CME's EPS stood at $2.9.
CME Group had an annual EPS of $11.18, indicating an increase of 15.4% from $9.69 in 2024. The quarterly per-share earnings for the period ending Sep 30, 2026, was $2.9, indicating a 16.5% increase from the same quarter last year. CME's 12-month EPS stands at $12.29 as of September 2026. CME Group's annual EPS in 2024 stood at $9.69, a 9.2% increase year-over-year.
During the last 12 months, CME Group has seen an EPS growth of 16.5% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 14.7% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 13.7%. A 10-year view shows that CME has seen an average EPS growth of 11.7% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| ICE Intercontinental Exchange Inc | 24.25 | 20.6% | 30.8% | 8.8% |
| CME CME Group Inc - Class A | 25.87 | 15.4% | 14.7% | 13.7% |
| CBOE Cboe Global Markets Inc | 26.63 | 44.5% | 68.2% | 19.6% |
| NDAQ Nasdaq Inc - 144A | 29.32 | 60.8% | 11% | 10.5% |
| MSCI MSCI Inc | 34.75 | 11.6% | 13.4% | 16.9% |
All data is based on quarterly TTM periods, unless otherwise specified.